Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

A Look at Five Stocks Gaining Ground on Wednesday

Page 1 of 2

US stocks are trading in the red on Wednesday as traders await the release of minutes from the Federal Reserve’s July meeting, which might give clues on the rate hike timing.

Nevertheless, a number of stocks are trading higher today, including Valeant Pharmaceuticals Intl Inc (NYSE:VRX), Urban Outfitters, Inc. (NASDAQ:URBN), OSI Systems, Inc. (NASDAQ:OSIS), MeetMe Inc (NASDAQ:MEET), and Lumber Liquidators Holdings Inc (NYSE:LL). Let’s take a closer look at the events that sent these stocks higher and analyze the hedge fund sentiment towards them.  

accounting, desk, market, funds, economy, business, income, gains, value, wealth, revenue, pen, analysis, foreign, balanced, computer, management, graph, risk, equities, earnings, pie, chart, stocks, money, monetary, high, accountant, growth, low, invest, ratio, quotes, account, workplace, profits, trade, investment, return, office, banking, man, index, financial, hand, businessman, results, performance, exchange, capital

Nonwarit/Shutterstock.com

Through extensive research, we have determined that the best approach to outperform the broader indices is to follow hedge funds into their top small-cap ideas. In our backtests, a portfolio of the 15 most popular small-cap stocks generated monthly alpha of 81 basis points, versus 0.7 percentage points posted by hedge funds’ top large- and mega-cap picks (see more details here).

Morgan Stanley Bullish on Valeant Pharmaceuticals

Valeant Pharmaceuticals Intl Inc (NYSE:VRX)’s stock has gained over 14% so far today after Morgan Stanley upgraded the company to ‘Overweight’ from ‘Equal weight’ and upped its price target to $42 from $33 as the investment firm  believes that the risk of “severe” financial stress is abating because the company is renegotiating its covenants and paying the debts. Morgan Stanley’s analyst David Risinger said in a report that the Canadian medical company has strong growth prospects under its new CEO, Joe Papa. Mr. Risinger thinks that if Valeant’s Enterprise Value remains constant, deleveraging would result in higher equity value accretion. Earlier this week, Mizuho Securities also upgraded Valeant to ‘Neutral’ following reports that the company placed an offer to pay lenders a higher interest rate in order to amend its debt agreements. Activist Bill Ackman’s Pershing Square owns 21.59 million shares of Valeant Pharmaceuticals as of the end of June.

Follow Valeant Pharmaceuticals International (NYSE:VRX)
Trade (NYSE:VRX) Now!

Urban Outfitters Posts Impressive Q2

Urban Outfitters, Inc. (NASDAQ:URBN)’s stock has surged by some 16% on the back of the company posting better-than-expected results for the second quarter. Overall, the Philadelphia-based lifestyle retail company earned $0.66 per share on revenue of $890.6 million during the quarter, surpassing the consensus estimates of $0.56 and $886.84 million, respectively. In addition, comparable-store sales rose 1%, while analysts had expected a decline of 1.2%. Jim Simons’ Renaissance Technologies owns about 1.25 million shares of the company, according to its last 13F filing

Follow Urban Outfitters Inc (NASDAQ:URBN)
Trade (NASDAQ:URBN) Now!

On the next page, we will discuss the other three stocks that are trading higher today.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!